Related Experiment Video
Updated: Jul 11, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Peutz-Jeghers syndrome: clinicopathology and molecular alterations
1Division of Gastroenterology and Hepatology, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, P. O. Box 850 H045, Hershey, Pennsylvania 17033-0850, USA. tmcgarrity@psu.edu
Insights
Peutz-Jeghers syndrome (PJS) is an inherited disorder causing intestinal polyps and increased cancer risk. Genetic defects, primarily in the LKB1 gene, are linked to PJS, though other genetic factors may also be involved.
Area of Science:
- Genetics
- Oncology
- Gastroenterology
Background:
- Peutz-Jeghers syndrome (PJS) is a rare inherited disorder characterized by intestinal polyposis and mucocutaneous pigmentation.
- PJS significantly increases the risk of developing various intestinal and extra-intestinal cancers.
- Clinical presentation of PJS exhibits variable penetrance and heterogeneity, complicating epidemiological assessments.
Purpose of the Study:
- To review the genetic basis of Peutz-Jeghers syndrome.
- To discuss the clinical management and evolving therapeutic strategies for PJS.
- To highlight the importance of genetic identification in assessing cancer risk.
Main Methods:
- Review of genetic linkage studies identifying chromosome 19p involvement in PJS.
- Analysis of LKB1 (serine/threonine kinase) gene mutations in PJS patients.
- Examination of LKB1 mouse knockout models for phenotypic correlation.
- Consideration of PJS kindreds with unlinked LKB1 mutations.
Main Results:
- A defect in the LKB1 gene is identified in a majority of Peutz-Jeghers syndrome cases.
- LKB1 gene mutations are strongly associated with PJS and associated cancer predisposition.
- The existence of PJS cases without LKB1 mutations suggests potential alternative genetic loci.
Conclusions:
- Genetic mutations, particularly in LKB1, are central to the pathogenesis of Peutz-Jeghers syndrome.
- Advances in endoscopic technology offer improved management of intestinal polyposis in PJS.
- Accurate genetic profiling is crucial for precise clinical course assessment and cancer risk stratification in PJS patients.
Abstract:
Peutz-Jeghers syndrome (PJS, OMIM 175200) is an unusual inherited intestinal polyposis syndrome associated with distinct peri-oral blue/black freckling. Variable penetrance and clinical heterogeneity make it difficult to determine the exact frequency of PJS. PJS is a cancer predisposition syndrome. Affected individuals are at high risk for intestinal and extra-intestinal cancers. In 1997, linkage studies mapped PJS to chromosome 19p, and subsequently a serine/threonine kinase gene defect (LKB1) was noted in a majority of PJS cases. A phenotypically similar syndrome has been produced in an LKB1 mouse knockout model. Several PJS kindred without LKB1 mutations have been described, suggesting other PJS loci. The management of PJS is complex and evolving. New endoscopic technologies may improve management of intestinal polyposis. Identification of specific genetic mutations and their targets will more accurately assess the clinical course, and help gage the magnitude of cancer risk for affected individuals.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cellular Adaptation IV: Dysplasia and Metaplasia
Cushing Syndrome II: Pathophysiology

